5 completed, 2 active not recruiting, 1 withdrawn. 3 Early Phase 1, 3 Phase 2, 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Skin Basal Cell Carcinoma: new trials by email Literature Review of Skin Basal Cell Carcinoma trials Research Report on Skin Basal Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma Biopsy Procedure, Natural Killer Cell Therapy, Surgical Procedure - Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma | Early Phase 1 | Completed | Ohio State University Comprehensive Cancer Center | 4 | 2025-10-16 | 2026-09-28 |
| Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients Best Practice, Educational Activity, Patient Observation - Skin Basal Cell Carcinoma | Not applicable | Active not recruiting | University of Michigan Rogel Cancer Center | 81 | 2024-10-08 | 2026-06-23 |
| Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer Arsenic Trioxide, Itraconazole, Laboratory Biomarker Analysis - Skin Basal Cell Carcinoma | Early Phase 1 | Withdrawn | Jean Yuh Tang | 2020-12-01 | 2020-10-22 | |
| Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer Remetinostat - Skin Basal Cell Carcinoma | Phase 2 | Completed | Kavita Sarin | 30 | 2018-07-07 | 2021-06-08 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Biopsy Procedure, Biospecimen Collection, Computed Tomography - Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 68 | 2017-09-27 | 2026-11-18 |
| Topical Itraconazole in Treating Patients With Basal Cell Cancer Itraconazole, Placebo - Skin Basal Cell Carcinoma | Early Phase 1 | Completed | Jean Yuh Tang | 9 | 2016-05-05 | 2019-04-11 |
| Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer Pembrolizumab, Vismodegib - Skin Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | Anne Chang | 16 | 2016-02-01 | 2019-03-08 |
| Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery Therapeutic Conventional Surgery - Skin Basal Cell Carcinoma | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 179 | 2011-12-07 | 2025-04-29 |
Carcinoma, Basal Cell (8) · Adenocarcinoma, Papillary (1) · Carcinoma, Basosquamous (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Signet Ring Cell (1) · Eccrine Porocarcinoma (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Microcystic adnexal carcinoma (1) · Muir-Torre Syndrome (1) · Mycosis Fungoides (1) · Paget Disease, Extramammary (1) · Sezary Syndrome (1)
Carcinoma (8) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms, Basal Cell (8) · Neoplasms, Glandular and Epithelial (8) · Adenocarcinoma (1) · Carcinoma, Neuroendocrine (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Genetic Diseases, Inborn (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1)
Biopsy (2) · Itraconazole (2) · Arsenic Trioxide (1) · HhAntag691 (1) · Nivolumab (1) · Observation (1) · Practice Guidelines as Topic (1) · Specimen Handling (1) · Standard of Care (1) · Surgical Procedures, Operative (1) · Watchful Waiting (1) · arsenous acid (1) · pembrolizumab (1) · remetinostat (1) · talimogene laherparepvec (1)
Jean Yuh Tang (2) · Anne Chang (1) · Kavita Sarin (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of Michigan Rogel Cancer Center (1)
United States (7)
Allison Billi (1) · Anne Lynn S Chang, MD (1) · Anthony Oro (1) · Jason Lee, MD (1) · Jean Tang (1) · Kavita Sarin (1) · Kirsten Johnson, MD (1)
P30CA124435 (2), UM1CA186709 (1), UM1CA186716 (1)